Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 15, Number 3—March 2009

Dispatch

Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in a Malian Orphanage

Didier TandéComments to Author , Nelle Jallot, Flabou Bougoudogo, Tracey Montagnon, Stéphanie Gouriou, and Jacques Sizun
Author affiliations: Brest University Hospital, Brest, France (D. Tandé, N. Jallot, T. Montagnon, S. Gouriou, J. Sizun); Bretagne Occidentale University, Brest (D. Tandé, S. Gouriou); National Institute of Research in Public Health, Bamako, Mali (F. Bougoudogo)

Suggested citation for this article

Abstract

We show high rates of extended-spectrum β-lactamase–producing Enterobacteriaceae carriage among the staff and children at an orphanage in Bamako, Mali. Enterobacteriaceae colonized in 100% and 63%, respectively, of the 38 children and 30 adults studied. Use of antimicrobial drugs appeared excessive and inappropriate; decontamination and hygiene protocols were also questioned.

Extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae pose a major health problem because the incidence rate of infection is particularly high (13), and delays in the prescription of appropriate antimicrobial drug therapy for these infections are a risk factor for poor prognosis and death (4). In the 36 months preceding our study, children adopted by French families, and who were followed up at the Brest University Hospital, were shown to be carriers of ESBL-producing Enterobacteriaceae. All of these children had resided at the state orphanage in Bamako, Mali.

The dominant, and consequently widespread, manifestation of ESBL-producing Enterobacteriaceae in these children was the catalyst for our prospective investigation. We studied the carriage rate of these bacteria for the children and personnel of the orphanage and also the living conditions within the orphanage.

The Study

This prospective cross-sectional study was conducted during September 10–19, 2003. The study population included 44 staff members and 39 children who were residing in the orphanage on the day the bacteriologic samples were taken. Adults were included on a voluntary basis and gave informed consent. Informed consent for the children was obtained from their legal representative, the director of the orphanage. Anonymity of participants was guaranteed.

We examined clinical data from charts as well as lifestyle habits, including personal and environmental hygiene. Environmental samples and children’s stool samples were obtained. Adults obtained their own stool samples. Environmental samples comprised potable tap water (1 sample) and surface samples (2 silicone bottle nipples, 1 child toilet, 2 faucets, and 1 sink that served as both a dishwashing and child-bathing station).

Samples were stored at 4°C and were sent by air within 18 hours to the microbiology laboratory of Brest University Hospital for analysis. Immediately upon arrival, the samples were injected into a Drigalski medium (bioMérieux, Marcy l’Etoile, France) supplemented with ceftazidime at 2 mg/L. This medium allows for selective isolation of resistant gram-negative bacteria. Colonies that developed on this medium showed different shapes and were systematically identified by using the API20E system (bioMérieux). Antimicrobial-drug susceptibility patterns were determined by the disk-diffusion method, as defined by the Committee for Antimicrobial Susceptibility Testing of the French Society for Microbiology (5). Enterobacteriaceae were considered ESBL producers if synergy between third-generation cephalosporins and amoxicillin associated with clavulanic acid was detected (5,6).

Of the 30 adults sampled, 19 (63%) were found to be colonized with 1–3 ESBL-producing Enterobacteriaceae of the same or different species (9 samples showed 1 strain; 7 showed 2 strains, and 3 showed 3 strains). More carriers were found in the caregiver adult group, who had direct contact with the children, than in those with less interactive responsibilities (e.g., administration and housekeeping staff), 90% (16/18) versus 25% (3/12), respectively (p<0.0016).

We included 38 of the 39 children in the analysis; no stool sample was available for the remaining child. All children sampled carried 1–3 ESBL-producing Enterobacteriaceae (21 with 2 strains and 9 with 3 strains). Bacteria samples from children were colonized more often than that of adults with >1 ESBL-producing Enterobacteriaceae, 78% (30/38) and 52% (10/19), respectively (p = 0.04). Water samples collected contained no ESBL-producing Enterobacteriaceae. The other 6 environmental samples testing positive showed 1 (4 samples), 2 (1 sample), or 3 (1 sample) strains of ESBL-producing Enterobacteriaceae.

We isolated 118 strains of ESBL-producing Enterobacteriaceae: Escherichia coli (56%), Klebsiella pneumoniae (36%), K. oxytoca (4%), and Citrobacter freundii (4%). Depending on the species, 36%–79% of strains were resistant to aminoglycosides, 20%–50% were resistant to fluoroquinolones, and >94% were resistant to cotrimoxazole.

Figure

Thumbnail of Representative XbaI pulsed-field gel electrophoresis profiles of extended-spectrum β-lactamase–producing Escherichia coli. Isolates denoted A originate from adults, P from children &lt;4 months of age, M from children 4–12 months of age, G from children &gt;12 months of age, and E and R from environmental samples.

Figure. Representative XbaI pulsed-field gel electrophoresis profiles of extended-spectrum β-lactamase–producing Escherichia coli. Isolates denoted A originate from adults, P from children <4 months of age, M from children 4–12 months of age,...

Clonal relatedness of the 52 E. coli ESBL-producing strains was assessed by pulsed-field gel electrophoresis (Figure). Among these, 12 unique subtypes and 15 clusters of 2–7 clonal strains were identified. Dissemination might follow an allodemic pattern, corresponding to the spread of multiple specific clones or genetic elements.

The high colonization rate for caregiver adults within our study (90%) could logically and predominantly be attributed to direct contamination from the children. Furthermore, the excessive use of antimicrobial drugs also contributes to the emergence and spread of multidrug-resistant bacteria, as previously stated by Harbarth and van de Sande-Bruinsma (7,8). The health records of the 39 children showed that 88 courses of antimicrobial drugs had been prescribed to 27 children during their stay at the orphanage during the 1,921 weeks that the children lived in the orphanage. Many of the antimicrobial drugs prescribed at the orphanage were used for infections of unlikely bacterial etiology. Many authors have emphasized that the inappropriate use of antimicrobial drugs, particularly among the children of various nonindustrialized nations, leads to antimicrobial resistance (9,10). However, this phenomenon also exists in developing nations (11). The antimicrobial drugs most frequently prescribed were third-generation cephalosporins and penicillins, which according to Colodner, favor the carriage of ESBL-producing Enterobacteriaceae (12). The dosages prescribed were not always adapted to the precise weight of the children, thereby favoring the development of resistance. In addition, the duration of antimicrobial drug therapy, which also favors the development of resistance, was often limited for economic reasons, (13,14).

We also suggest that dissemination of ESBL-producing Enterobacteriaceae within the orphanage might be explained by close contact between persons and massive contamination of the environment. With the exception of the water supply, all environmental samples tested positive despite compliance with posted hygiene rules and the best efforts and intentions of personnel. Feeding bottles were prepared on a bench top next to the sink, which was also used for bathing infants, and this sink was not regularly decontaminated during the day. Water was served in 1 shared drinking cup. Moreover, traditions such as eating from a shared plate and washing only 1 hand, along with a lack of material and financial means, appeared to clearly favor ESBL-producing Enterobacteriaceae colonization in the children. Childcare personnel washed their hands with soap and a diluted bleach solution before and after each caregiving interaction. Taps were operated manually without any particular contamination precautions. These environmental hygiene conditions contributed to the dissemination of the multidrug-resistant strains of Enterobacteriaceae.

Although this study gives a precise idea of the situation at the orphanage, our study has limitations. 1) The kinetics of colonization within the orphanage remain unknown; 2) the lack of a control group without ESBLs does not allow a comparison of the antimicrobial drug use; and 3) the rate of ESBL-producing Enterobacteriaceae carriage overall in Malian children of similar age and sex has not been scientifically determined.

Conclusions

This study provides evidence that the carriage of ESBL-producing Enterobacteriaceae is prevalent at the orphanage in Bamako; dissemination is widespread among children and staff and within the environment. We identified 2 key factors responsible for this type of epidemic: 1) inadequate hygiene conditions favoring the spread of ESBL-producing Enterobacteriaceae in the environment and 2) the qualitative and quantitative inappropriate use of antimicrobial drugs. We therefore strongly recommend implementation of appropriate hygiene practices to limit colonization. Of equal importance is the coupling of these measures with a targeted and reasonable approach to the use of antimicrobial drugs.

Our results raise questions about the importance of quickly and accurately identifying persons who carry ESBL-producing Enterobacteriaceae because initiation of appropriate antimicrobial drug therapy may be delayed for infected patients and infection could spread rapidly. Testing for ESBL-producing Enterobacteriaceae in stools appears to be justified as part of the initial examination of all adopted children who have lived in an institution where these microorganisms are endemic.

Dr Tandé is a clinical microbiologist who works closely with the infectious disease specialists at Brest University Hospital, Brest, France. He is particularly involved in the study of changes in microbial ecology caused by antimicrobial drug therapy.

Acknowledgment

We thank the authorities of the Republic of Mali for their authorization and assistance, particularly M. Attaher, A. Toure, T. Sidibe, T. Tandia, and N. Ouattara. We also gratefully acknowledge Nolwenn Ferre for technical assistance.

References

  1. Comité Technique National des Infections Nosocomiales. Maîtrise de la diffusion des bactéries multi-résistantes aux antibiotiques. Recommandations pour les établissements de santé. Ministère de l’emploi et de la solidarité, Secrétariat d’Etat à la Santé et à l’Action Sociale; 1999. p. 5–14.
  2. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. JAMA. 1999;281:6771. DOIPubMed
  3. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13:1–11 [cited 2009 Jan 26]. Available from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044
  4. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:116271. DOIPubMed
  5. Cavallo JD, Chardon H, Chidiac C, Choutet P, Courvalin P, Dabernat H, Comité de l’Antibiogramme de la Société Française de Microbiologie, Communiqué janvier. 2007. [cited 2009 Jan 26]. Available from http://www.sfm.asso.fr
  6. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:65786. DOIPubMed
  7. Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis. 2005;11:794801.PubMed
  8. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14:172230. DOIPubMed
  9. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use in acute respiratory infections in the United States. Clin Infect Dis. 2001;33:75762. DOIPubMed
  10. Schwartz B. Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: the case for judicious antimicrobial use. Clin Infect Dis. 1999;28:2113. DOIPubMed
  11. World Health Organization. Promoting rational use of medicines: core components. Geneva. WHO/EDM/2002.3. Geneva: The Organization; 2002.
  12. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23:1637. DOIPubMed
  13. World Health Organization. Antibiotic prescribing in the West African countries: Mauritania, Niger and Senegal. (WHO/DAP/93.4).Geneva: The Organization; 1993
  14. Avorn JL, Barrett JF, Davey PG, McEwen SA, O’Brien TF, Levy SB. Antibiotic resistance: synthesis of recommendations by expert policy groups. Alliance for the prudent use of antibiotics. WHO/CDS/CSR/DRS/2001.10. Geneva: World Health Organization. 2001.

Figure

Suggested citation for this article: Tandé D, Jallot N, Bougoudogo F, Montagnon T, Gouriou S, Sizun J. Extended-spectrum β-lactamase–producing Enterobacteriaceae in Malian orphanage. Emerg Infect Dis [serial on the Internet]. 2009 Mar [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/3/07-1637.htm

DOI: 10.3201/eid1503.071637

Top of Page

Table of Contents – Volume 15, Number 3—March 2009

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Didier Tandé, Laboratoire de Microbiologie, CHU Brest, 5 Avenue FOCH 29609, Brest Cedex, France;





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO